Skip to content

Clinical trials

Phase 1/2 Bronchiolitis Obliterans Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 1/2 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20061
20071
20102
20113
20122
20131
20143
20163
20171
20182
20194
20202
20211
20221
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated5
Recruiting3
Active, not recruiting2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Genta Incorporated2
H. Lee Moffitt Cancer Center and Research Institute2
M.D. Anderson Cancer Center2
Pharmacyclics LLC.2
Alexion Pharmaceuticals, Inc.1
Beth Israel Deaconess Medical Center1
Charles Cox1
Dana-Farber Cancer Institute1
Dartmouth-Hitchcock Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome34
Graft vs Host Disease6
Hematologic Neoplasms4
Leukemia4
Leukemia, Lymphocytic, Chronic, B-Cell3
Brain Injuries, Traumatic2
Lymphoma, Follicular2
Neoplasms2
Stroke2
Wounds and Injuries2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.